Specialty Enzymes Market 2022 | New Business Opportunities I...| MENAFN.COM

Friday, 09 December 2022 12:50 GMT

Specialty Enzymes Market 2022 | New Business Opportunities Is Expected To Hit $2.2 Billion By 2031


(MENAFN- EIN Presswire)

Specialty Enzymes Market

Specialty Enzymes Market | Asia Pacific is estimated to grow at a faster CAGR during forecast period.

PORTLAND, OREGON, UNITED STATE, August 25, 2022 /EINPresswire.com / -- According to the report published by Allied Market Research, the global specialty enzymes market accrued $1.2 billion in 2021, and is predicted to garner $2.2 billion by 2031, registering a CAGR of 6.7% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chain, regional landscape, and competitive scenario.

Rise in occurrence of chronic disorders such as arthritis and cancer boosts the global specialty enzymes market growth. Moreover, surge in geriatric population prone to chronic ailments has enhanced use of specialty enzymes in the biotechnology sector. This factor supplements the market growth. New product launches, rise in research and development activities related to enzyme treatment, and surge in clinical trials and number of hospitals will create new growth opportunities for the market.

Download Sample Report-

KEY FINDINGS OF THE STUDY

By type, the carbohydrases segment was the highest contributor to the specialty enzymes industry in 2021.
By application, the pharmaceuticals segment was the highest contributor to the market in 2021.
By source, the microorganism's segment is projected to grow at a significant CAGR of 6.3% from 2022 to 2031.
By region, North America garnered largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 8.8% during the review period.

COVID-19 Scenario

The COVID-19 outbreak is anticipated to have a negative impact on the growth of the specialty enzymes market due to the implementation of lockdown in many countries. The COVID-19 pandemic creates difficulty for pharmaceutical industry to focus on R&D activities including biosimilar development. These measures had a significant impact on the global economy, affecting a variety of industries. In addition, there is delay in product approval and product launch due to pandemic situations which further restricts the expansion of biosimilar market. Furthermore, most of the clinical trials are postponed to avoid spread of infections which slows down the drug development process

Based on the application, the pharmaceuticals segment accounted for the largest share of the market in 2021, contributing to nearly half of the overall share of the global specialty enzymes market. Moreover, this segment is predicted to record the highest CAGR of 6.7% from 2022 to 2031. The report also analyzes the segments including biotechnology research & development and diagnostics.

Based on type, the carbohydrases segment accounted for the largest share of the market in 2021, contributing to nearly half of the overall share of the global specialty enzymes market. However, the polymerases & nucleases segment is anticipated to record the highest CAGR of 10.0% from 2022 to 2031.

Based on the region, North America contributed toward the highest market share in 2021, accounting for nearly two-fifths of the market. However, the Asia-Pacific specialty enzymes market is set to register the fastest CAGR of 8.8% from 2022 to 2031.

Get a detailed COVID-19 impact analysis on the Specialty Enzymes Market -

Furthermore, factors that drive growth of the specialty enzymes market share include increase in R&D for development of enzyme therapy, increase in clinical trials, new product launches, and rise in number of hospitals. For instance, in May 2020, MediWound Ltd., a fully-integrated biopharmaceutical company expanded the distribution of NexoBrid (Bromelain-based enzymatic debridement) in Europe for treatment of burns. Furthermore, rise in awareness and increase in acceptability of enzyme-based treatment by medical practitioners contributes toward growth of the specialty enzymes market.

The specialty enzymes market trends is segmented on the basis of application, source, type, and region. By application, the market is classified into pharmaceuticals, biotechnology research & development, and diagnostics. On the basis of source, it is divided into microorganisms, plants, and animals. By type, it is divided into carbohydrase, proteases, lipases, polymerases & nucleases, and other enzymes. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA

Key players profiled in the global specialty enzymes market research report are International Flavors and Fragrances Inc., Alphazyme LLC, Novoenzymes, Amano Enzyme, Biocatalyst, Specialty Enzymes and Probiotics, Antozyme Biotech, Enzyme Development Corporation, BBI Solution, and Enzyme Supplies Ltd.

We also Offers Regional and Country Reports-

Japan Specialty Enzymes Market
South Korea Specialty Enzymes Market
Singapore Specialty Enzymes Market
Europe Specialty Enzymes Market
Indonesia Specialty Enzymes Market
Australia Specialty Enzymes Market
Taiwan Specialty Enzymes Market
US Specialty Enzymes Market

Trending Reports in Healthcare Industry-

Insomnia Market

Blood Market

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of 'Market Research Reports' and 'Business Intelligence Solutions.' AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

MENAFN25082022003118003196ID1104754310


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.